rheumatoid arthritis - AbbVie, Lilly Face Fresh Delays in FDA Approval for Expanded Use of Arthritis Drugs

AbbVie and Lilly are facing fresh delays in the approval of their respective rheumatoid arthritis drugs for treating the chronic skin disease eczema as the US health regulator...